Company / Inventory
United Therapeutics Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$183.1M
FY2025
5-year range
$93.8M / $183.1M
FY2021-FY2025
Trend
+16.0%
vs FY2024
Sector context
#30 of 105
Health Care
What the data says
At $183M, United Therapeutics's inventory ranks #30 of 105 in the Health Care sector. Inventory has increased for 5 consecutive years, from $87M in FY2020 to $183M in FY2025.
Based on SEC 10-K filings.
$183M in FY2025 with a 5-year CAGR of +16.2%.
Improved from $112M to $183M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +21.5%
- 5-Year CAGR
- +16.2%
- 10-Year CAGR
- -
Sector benchmark
#30 of 105 in Health CareTop 29% of 105This company $183.1M Sector average $885.3M
▼
-79.3% below sector average
Key checks
Key Insights
- United Therapeutics's inventory has grown for 5 consecutive years.
- 5-year CAGR of +16.2%, indicating consistent growth.
- In FY2025, inventory increased 16.0% year-over-year.
- Ranks #30 out of 105 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 6.00 (safe zone, above 2.9 threshold)
- Strong profit margin: 40.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $183.1M | +16.0% |
| FY2024 | $157.9M | +41.2% |
| FY2023 | $111.8M | +9.6% |
| FY2022 | $102.0M | +8.7% |
| FY2021 | $93.8M | +8.4% |
| FY2020 | $86.5M | -7.4% |
| FY2019 | $93.4M | -7.5% |
| FY2018 | $101.0M | -6.4% |
| FY2017 | $107.9M | +7.9% |
| FY2016 | $100.0M | +23.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026